RSS
FEATURES |
eBUSINESS |
HR |
MANAGEMENT |
MARKETING |
ENTREPRENEUR |
SMALL BUSINESS
INDUSTRIES:
Biotech & Biotechnology Jobs, Job Listings & Careers Search
Find your next Biotech & Biotechnology career. Search Biotech & Biotechnology jobs from thousands of job and career search sites.
A search engine for jobs with a different approach to job and career searches. In one simple search, job
seekers get free access to millions of employment opportunities from thousands of websites.
Find your next job in Biotech & Biotechnology today.
Celgene Makes $15M Equity Investment in Acetylon to Support HDAC Inhibitor ... - Genetic Engineering News
Genetic Engineering News
Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, ...
IDT Buys 1st Base Custom Oligo Business to Serve Clients in Asia - Genetic Engineering News
Genetic Engineering News
IDT provides custom DNA and RNA oligonucleotides and genes to academic, government, and commercial clinets in the biotech, clinical diagnostics, and pharmaceuticals sectors. The firm claims to synthesize and ship an average of 36000 oligos per day.
Big VC Biotech Spending on the Rise for 2012 - EON: Enhanced Online News (press release)
EON: Enhanced Online News (press release)
(EON: Enhanced Online News)--As Rainbow BioSciences, the biotech division of Rainbow Coral Corp. (OTCBB: RBCC), continues to vet investment banks to assist with its capital raise, investors remain optimistic on the returns that new biotech firms can ...
FDA Okays Shire's ADHD Drug Vyvanse for Maintenance Therapy in Adults - Genetic Engineering News
Genetic Engineering News
Subscribe to our daily and weekly e-Newsletters to get our biotech news coverage delivered to your inbox. Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since ...
Palatin Technologies to Present at 14th Annual BIO CEO & Investor Conference - Sacramento Bee
Sacramento Bee
Hosted by the Biotechnology Industry Organization (BIO), the 14th Annual BIO CEO & Investor Conference will take place February 13-14 at the Waldorf=Astoria Hotel, New York, NY. Carl Spana, Ph.D., President and Chief Executive Officer of Palatin ...
Biotechnology Industry Starts Strong in 2012 -- MannKind and Celsion Look to Rally - MarketWatch (press release)
MarketWatch (press release)
NEW YORK, NY, Feb 07, 2012 (MARKETWIRE via COMTEX) -- Biotech stocks are on fire in 2012. The iShares NASDAQ Biotechnology index is up more than 15 percent year-to-date as impressive earnings results have boosted investor optimism in the industry.
Neuralstem President and CEO to Present at BIO CEO & Investor Conference 2012 - FierceBiotech
Proactive Investors USA & Canada
FierceBiotech
Now in its 14th year, the BIO CEO & Investor Conference is billed as the largest independent investor conference focused on publicly traded biotechnology companies. Neuralstem's President and CEO Richard Garr is also scheduled to present at the 6th ...
StemCells, Inc. to Present at 2012 BIO CEO Investor Conference
Aradigm to Present at the Biotechnology Industry Organization (BIO) CEO ...
Outlook for biotech crop adoption indicates continued global growth - EON: Enhanced Online News (press release)
EON: Enhanced Online News (press release)
MANILA, Philippines--(EON: Enhanced Online News)--Global adoption of biotech crop technology continues at unprecedented rates. During 2011, an additional 12 million hectares were planted representing an annual growth rate of 8 percent over 2010, ...
3 Biotech Companies Down But Not Out - Seeking Alpha
Seeking Alpha
When it comes to speculative biotech investing, one can at times make a connection to the sport of boxing. What often occurs with these companies is that for one reason or another they suffer major setbacks. These setbacks can occur for a variety of ...
'Nigeria still a spectator in N41bn global biotechnology industry' β PSN President - Vanguard
Vanguard
Azubuike Okwor, says despite the injection of N200 billion Pharmaceutical Development Fund by the Federal Government, Nigeria is but only a spectator in the 41 billion naira global biotechnology industry. Excerpts: What is the state of the ...
biotechnology news - Google News
Google News